肝脂肪变性对慢性乙型肝炎功能性治愈的影响:临床证据与机制研究
The impact of hepatic steatosis on functional cure in chronic hepatitis B:clinical evidence and mechanistic research
摘要
随着代谢相关脂肪性肝病(metabolic dysfunction-associated steatotic liver disease,MASLD)与慢性乙型肝炎(chronic hepatitis B,CHB)共病率的持续上升,这一特殊人群的临床管理面临重大挑战.肝脂肪变性可能通过调控肝细胞代谢微环境和免疫应答,在促进乙肝表面抗原(hepatitis B virus surface antigen,HBsAg)清除和抑制乙型肝炎病毒(hepatitis B virus,HBV)复制方面发挥独特作用.然而,这种潜在的抗病毒获益可能被伴随的代谢异常所抵消,特别是在肝纤维化进展和肝癌发生风险方面呈现出显著的异质性.本文系统梳理最新临床证据,深入剖析脂肪肝影响CHB自然史的分子机制,探讨代谢干预在优化抗病毒疗效中的潜在作用,为优化CHB患者的功能性治愈策略和个体化精准管理提供重要理论基础和实践指导.
With the escalating global prevalence of metabolic dysfunction-associated steatotic liver disease(MASLD)coexisting with chronic hepatitis B(CHB),the clinical management of this dual-disease population has emerged as a formidable challenge.Recent studies have revealed that hepatic steatosis may exert a paradoxi-cal influence on the natural history of hepatitis B virus(HBV)infection.On one hand,it appears to facilitate hepatitis B surface antigen(HBsAg)clearance and suppress HBV replication,likely through remodeling the he-patocyte metabolic microenvironment and modulating immune responses.On the other hand,these potential anti-viral advantages are frequently counterbalanced by metabolic dysregulations,which contribute to heterogeneous outcomes in liver fibrosis progression and hepatocellular carcinoma(HCC)risk.This review comprehensively synthesizes the latest clinical evidence and delves into the underlying molecular mechanisms through which he-patic steatosis shapes CHB progression.Furthermore,it explores the promising role of metabolic interventions in augmenting antiviral therapy,thereby providing a robust theoretical foundation and actionable guidance for opti-mizing functional cure strategies and advancing personalized precision care in CHB patients.
年,卷(期):
2026, 16(2)
分类号:
R512.62
机标分类号:
R285.5
R512.62
R373.2
在线出版日期:
2026年7月2日
基金项目:
MX202406:中国肝炎防治基金会沐新慢乙肝科研基金项目iGandanF-1082024-LG004:北京肝胆相照公益基金会科研项目BK20231118:江苏省自然科学基金面上项目ICM2024002:南京大学中医研究院中西医协同研究开放课题ICM2024032:南京大学中医研究院中西医协同研究开放课题,